INTRODUCTION
Primary Sjögren's Syndrome (pSS) is an autoimmune disorder characterized by eye dryness and salivary hypofunction due to inflammation of lacrimal and salivary glands [1] . The incidence of pSS in women is higher than men and the highest incidence of disease at about 40-50 years in women [2] [3] [4] .
The different anatomical regions of the auditory system may be affected by pSS resulting in symptoms such as otalgia, tinnitus, vertigo, hearing loss. There is little research into description of the pathophysiological impact that pSS may have on the human auditory system. Whilst there is no robust finding about effects of pSS especially for outer ear and middle ear, the possible reasons for auditory symptoms are thought to be dryness of the ear canal epidermis, middle and inner ear fluids, and dysfunction of the Eustachian tube [5, 6] . On the other hand, there are many hypotheses about the pathophysiological impact of pSS into the inner ear. The inner ear is defined as a sensory organ which contains perilymph and endolymph fluid and it transduces the soundwaves into senses of hearing to use by auditory neural parts. These neurosensory functions are tightly bound to the regulation of molecules in the perilymph and endolymph fluid volume in the inner ear [6] . The change in the volume of the inner ear fluids can disrupt the molecular structure of the fluids and cause hearing loss.
Additionally, ototoxic drugs used during the treatment of autoimmune inner ear diseases can cause the damage of intracellular fluids and differentiate the molecular concentrations for physiological mechanisms. Furthermore, the autoantibodies are produced in perilymph and endolymph fluids in normal hearing physiology, but in the diseases such as pSS they are produced inadequately [5, 6] . Some studies show that the incidence of mild to severe hearing loss in patients with pSS was predicted as 78.38%, though many patients were unaware of their hearing loss [7] . Other studies assert that the patients with pSS have higher hearing thresholds than the healthy subjects in the 500-3000 Hz frequency range [8] , and the recent researches have concentrated on high frequency hearing loss in pSS [8, 9] . Whilst the present paper concentrates on medial olivocochlear system functions in pSS, also hearing loss, including high frequency hearing loss, is evaluated roughly.
In diagnosis of hearing loss and medial olivocochlear efferent system functions, otoacoustic emissions (OAEs) test is the one of crucial clinical and diagnostic tool, because it reveals the cochlear component of a hearing impairment. The (OAEs) are generated by active micromechanics of the outer hair cells (OHCs) in the organ of Corti and they are low-intensity sounds produced by cochlea as a part of normal auditory process [10] Especially, distortion product otoacoustic emissions (DPOAEs), precisely detect the cochlear dysfunction as frequency-specific and they are obtained in spite of hearing loss at some degrees, so they are preferred for assessment of the cochlear activity and medial olivocochlear efferent system functions in the present research.
Moreover, the suppression of OAEs means that a fair amount of decrease in the response amplitude with contralateral ear stimulation which reduces the electro motility of the OHCs, and in particular suppresses OAEs. The suppression is related to efferent auditory pathway which originates from the superior olivary complex. Since the contralateral sound-induced suppressive effect is mediated by the medial superior olivary complex (MSOC) neurons, contralateral suppression of OAEs gives direct information on MSOC efferent activation. If the contralateral ear is stimulated when noise is presented, it can give an idea. This effect is explained by the change of cochlear micromechanics of MSOC which can be activated by contralateral acoustic stimulation [11] . The present study therefore explored the suppression of emissions to investigate the medial olivocochlear system in pSSG. Since, MOC efferent system provides better hearing performance and speech discrimination in noisy environments; disruption of the MOC system which can be evaluated by suppression of OAE causes abnormalities of temporal functions like discrimination, understanding and lateralization of sounds in a noisy environment [12] .
However, there is little research into medial olivocochlear efferent system function in pSS [8, 12] . Therefore, this study is the first to evaluate the functions of the MOC efferent related to neurosensory functions in pSSG by using contralateral suppression of DPOAEs. The reason we expected MOC dysfunction in pSS patients is adversely affected to neurosensory functions in the inner ear fluids and upper auditory pathway. To reveal the important of the routine audiological evaluations in pSSG, the study also investigated the other audiological findings extensively.
METHODS
All the subjects agreed to participate in this randomized controlled study and signed an informed consent prior to the investigation. In addition to this, the study performed with decision number of 396 for ethical approval. The pSS patients meeting classification criteria for primary Sjögren's syndrome were evaluated for eligibility [13] . After physical and laboratory examination, disease activity was measured with EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) and patients with ESSDAI <14 were referred.
The exclusion criteria included high disease activity (ESSDAI ≥ 14), exposure to noise, genetically hearing loss, neurological disease, tinnitus, vertigo, ototoxic medication, trauma, ear pathologies or ear surgery history and who are older than 75 years. A total of thirty-six pSS patients were enrolled as the study group and thirty-six age and gender matched healthy subjects with normal hearing thresholds were enrolled as the control group. Since hydroxychloroquine (HCQ) is frequently used in pSS and antimalarial drugs are suspected to cause ototoxicity, hearing performance of HCQ users and non-users were also compared as subgroup analysis in order to investigate possible ototoxic effects of HCQ.
Pure Tone -Speech Audiometry
All the audiological evaluations of the subjects were performed by the same audiologist in a silent cabinet with GSI-AudioStar Pro™ Clinical Audiometer as air conduction thresholds at frequencies of 125-8000 Hz and bone conduction thresholds at 500-4000 Hz. The high frequency hearing thresholds were found at frequencies of 9000, 10.000, 11.200, 12.500 Hz.
Hearing loss were classified as the low frequency (125, 250, 500 Hz), the middle frequency (500, 1000, 2000 Hz), the high frequency ( 4000, 6000, 8000 Hz) and very high frequency (9000, 10,000, 11.200, 12.500 Hz). The subjects with the limit of perception lower than 20 dB HL at all frequencies were defined as normal [14] . The pure tone thresholds averages were calculated at 500 Hz, 1000 Hz, 2000 Hz, 4000 Hz and hearing loss degrees were defined according to the criteria [14] . The speech audiometer was evaluated for Speech Recognition Thresholds (SRT), Speech Discrimination (SD) scores and they were compared between pSSG and control. The subjects who had speech discrimination scores above %88 were defined as normal [14] .
Acoustic Immitance
The acoustic immitance involves the middle ear pressure, the static compliances and the presence of ipsilateral and contralateral acoustic reflexes. 226 Hz tympanometry measurement and ipsilateral-contralateral acoustic reflexes were assessed with GSI TYPmpStar.
The subjects with middle ear pressures of 0 daPa to -100 daPa and compliance values of 0.33 mmHo to 1.33 mmHo were defined as normal. The acoustic reflexes of 75-95 dB in 500, 1000, 2000 and 4000 Hz frequency were considered normal [14] .
Otoacoustic Emissions
DPOAE measurement was performed with Interacoustic Eclipse 15 by using insert earphones.
The frequency ratio of the two primary tones (f2/f1) was fixed at 1.22. Stimulus levels were kept at 65 dB SPL for f1 and 55 dB SPL for f2 frequencies. DPOAE measurement at 2f1 -f2 was considered significantly different from the background noise if it exceeded it by at least 3 dB. DPOAEs were obtained between 1 kHz and 6 kHz, besides signal to noise ratio of these responses were compared between pSSG and controls. Additionally, the white noise at 50 dB SPL stimulated contralateral ear side during otoacoustic emission measurement to evaluate MOC activities [15, 17] .
Statistical Analyses
SPSS version 25 for Windows 7 was used for statistical analyses and a p value <0.001 was considered statistically significant. The variables were investigated using visual (histogram and probability plots) and analytical methods (Kolmogorov-Smirnov/ Shapiro Wilk's test) to determine whether or not they are normally distributed. Descriptive analyses were presented using mean and standard deviation for normally distributed variables, median and interquartile range for not normally distributed ones. The p values result from the Independent Samples t-test in the group which demonstrated normal distribution and Mann Whitney U test was applied for non-parametric situations.
RESULTS

Clinical Findings
After consulting inclusion and exclusion criteria, we assessed 36 female subjects (72 ears) with pSS and compared with 36 healthy female subjects (72 ears). The mean age of pSSG and controls were 51.42 ± 10.21 years (range 38-64 years) and 49.72 ± 4.19 years (41-59 years) respectively. The subjects in pSSG were diagnosed about 20 months ago. The clinical profile was summarized in Table I . These findings were given in the study as only descriptive statistics, so any correlation between clinical profile and auditory performance of pSSG was not analyzed. Many of the subjects with pSS complained about sometimes communication problems including speech discrimination, perception in noisy environments.
Audiological Findings
The (Table II) .
In all the frequency ranges, a statistically significant difference was found. (p<0.001) Accordingly, the hearing thresholds were obtained from both of the groups, increasing gradually towards very high frequency range. The most significant difference was calculated for the right ear in very high frequency range between pSSG and the control, because the thresholds were observed at 45.62 dB in pSSG, while the control had a threshold at 22.15 dB.
(p<0.001) Moreover, minimal to mild sensorineural hearing loss was observed in 52.77% of pSSG (n=19) according to pure tone averages. For very high frequencies (9000-12.500 Hz), in 30 subjects (83.33%) had high frequency hearing loss and the controls in the current study [18] .
The speech audiometry results showed a correlation between pure tone averages and (SRTs) for the two groups. In addition, SRTs were about 5-10 dB higher than pure tone averages. The SD scores were determined with mean and standard deviation 94.11±5.77% in pSSG and similarly 96.22±3.57% in the control. Consequently, the speech audiometry results were correlated with the hearing thresholds for all the subjects.
The tympanometry results of pSSG and those of the control were analyzed by middle ear pressure and static compliance values as shown in Table III . All the subjects had Type A curve; thus, the middle ear pressures and the static compliances were in normal range.
However, one point to be attended is that the static compliances of pSSG were less than those of the control and when these static compliances of pSSG compared with their controls, a statistically significant difference was found between groups. (p=0.000) Likewise, static compliances for right ear of pSS were about 0.49 mmHo, while 0.65 mmHo in their controls.
On the other hand, no statistically significant difference was found at the middle ear pressures between the groups (p=0.299, p=0.804).
The acoustic reflex thresholds of pSSG were higher than those of the control as ipsilateral or contralateral measurements and related to this the statistically significant differences were found in all the frequencies (p=0.000). (Table IV) . Furthermore, in generally the contralateral acoustic reflex thresholds were obtained higher than the ipsilateral ones.
The DPOAE responses were obtained from all the subjects, but there was no significant difference. (Table V ) (p>0.001). The response amplitudes of 1 kHz and 2 kHz were found to be higher than the other frequencies for both the groups and ear sides in general.
For suppression of DPOAEs, if the criterion of an amplitude decrease of > 1 dB was taken into account, a suppressive effect was obvious in pSSG and the control [19] . The contralateral sound caused suppression of the otoacoustic emission responses in subjects with pSS, therefore normal sensitivity to noise as the quality of sounds were perceived. The highest suppression levels were observed at 1 kHz as 2.64 dB for pSSG and as 2.60 dB for the controls (Table VI) ; however, there was no statistically significant difference calculated between the groups. (p=0.920) Neither was there any significant difference at 1 kHz for suppression levels, nor was any significant difference found at the other frequencies as shown in p values.
A total of 13 pSS patients were HCQ non-users due to various reasons (coexisting retinal disease, allergy, not preferred by physician etc.). Subgroup analyses revealed no significant difference in hearing performance between HCQ users and non-users (mean hearing tresholds, p = 0.612; mean middle ear pressure, p = 0.869; mean acoustic reflexes tresholds, p = 0.315; mean DPOAE amplitude, p = 0,281; mean DPOAE suppression level, p = 0.685, independent samples t-test). When compared to healthy subjects, HCQ non-users had impairment similar to general pSS population in the study (mean hearing tresholds, p = 0.03; mean middle ear pressure, p = 0.128; mean acoustic reflexes tresholds, p = 0.018; mean DPOAE amplitude, p = 0,035; mean DPOAE suppression level, p = 0.452, independent samples t-test).
DISCUSSION
This study is the first to reveal the functions of the MOC efferent system related to auditory neurosensory functions in pSSG and also examine the audiological findings extensively in pSSG.
We found the minimal to mild sensorineural hearing loss in more than half of our pSS subjects, possibly resulting from degeneration of inner ear fluids with pSS. Because the cochlea is a sensory organ which transforms auditory inputs to neurosensory functions, this mechanism is tightly dependent on the fluids in the inner ear which contain several proteins and other molecules. Similarly, the molecules of the inner ear fluids degenerate from secondary to Sjögren's Syndrome or Meniere's Disease and thus the hearing loss can be observed in subjects with pSS [5]. Accordingly, this study implies that the subjects with pSS are more likely to suffer the hearing loss than their controls compatible with the literature.
Even if the first aim of this study is not to evaluate the high frequency hearing loss, so and so the present study included small numbers subjects with pSS according to some other studies in the literature for investigate the only high frequency hearing loss. However, we examined these findings also because of some communication problems of our subjects with pSS.
Consequently, most of the subjects with pSS had hearing loss in both ears at very high frequencies (9000-12.500 Hz) by similarly the other studies [8, 9] . A significant difference at 125-250-500 Hz between the groups was obtained differently from some other studies [6] .
The statistically significant differences between pSSG and controls were detected not only in very high frequency but also in all frequency ranges, (low, middle, high, very high) unlike the other studies [7] . The auditory damage resulting from pSS were at very high frequency particularly in current study, which is supported by some other studies about high frequency audiometry thresholds of pSS [6, 8] . These findings can be based on the indefinite pathophysiological impact such as dryness effects on neurosensory elements in the inner ear that pSS may have on the auditory system. The high frequency hearing loss can be difficult to recognize in daily life, so many subjects with pSS are unaware of high frequency hearing loss.
For this reason, the high frequency audiometry should be carried out routinely. It is very important for early detection of hearing loss of not only the subjects with pSS but also the subjects with autoimmune diseases.
The present study also investigated middle ear pressures, static compliances and statistically analyses of these values between groups. There is little research which examined tympanometry results comprehensively [7, 8] . The only evidences about the type of tympanogram were presented in these studies. Not only was Type A curve obtained from all of the subjects, but also the static compliances of pSSG were less than those of the control in current study. For instance, many studies presented their results in most of rheumatoid arthritis subjects as only Type A tympanometry curve [8] ; but, the tympanic membrane structure, motility or middle ear fluids and muscle mechanism can suffer from pSS. Similarly, some studies reported that conductive hearing loss was observed in few parts of their subjects and they supposed that it could be dryness of mucous membranes of Eustachian tube and middle ear fluids [20] .
The acoustic reflex thresholds were obtained in the normal range for both the groups; therefore, a retrocochlear pathology was not considered for the subjects with pSS. The acoustic reflex thresholds in high frequency are higher than the low ones, which is expected as it is consistent with increased the high frequency hearing thresholds in pSSG.
The results of DPOAEs in all frequency ranges were observed in pSSG, but one point to be attended was that response amplitudes of pSSG at 6 kHz. This is consistent with the decreased hearing thresholds towards high frequencies in pSSG. There is no statistically significant difference for amplitudes between pSSG and those of the control, so OHCs function and cochlear nonlinearity mechanism can be considered as normal in the pSSG. This may be explained by minimal or mild of hearing loss in pSSG, because of the hearing loss degrees, and so the functions may not suffer. The about half of our subjects had minimal to mild hearing loss and possibly these otoacoustic emissions amplitudes can decrease gradually to high frequencies because of the hearing loss progressing towards very high frequencies, like some other studies [21] .
Lastly, it may be the most important point of this study, we investigated the auditory efferent neural pathway of pSS because of there is huge need to these evaluations of autoimmune disease. Because of only DPOAEs indicated that there are no direct implications about normal functions of the MOC efferent system, the present study therefore explored the suppression of emissions to investigate the medial olivocochlear system in pSSG for an abnormality of this system should be suspected. Since, disorders of the MOC efferent system which can be evaluated by suppression of OAE cause abnormalities of some auditory neural functions.
Nevertheless in this study, the demonstration of the normal functioning of the MOC reflex in subjects with pSS may indicate that the olivocochlear efferent system is functional.
Besides, because of some other physiological changes such as atrophy of the spiral ganglion cells due to pSS causes sensorineural hearing loss; therefore, the subjects with pSS may have neurological symptoms. The several autoantibodies which regulate the immune system suffer from the autoimmune diseases; so multiple problems like polyneuropathy can be revealed [22, 23] .
Ototoxicity is reported as a rare side effect of antimalarial drugs (24) . To clarify whether HCQ exposure interfered with the study results we performed subgroup analyses. Based on our subgroup analyses, exposure to HCQ did not seem to significantly affect auditory test results of pSS patients in this study.
CONCLUSION
The findings suggest that there is no synchronization problem in the efferent system, but the knowledge about central afferent auditory system can be assumed by only acoustic reflexes in the present study. On the other hand, there is a need for more audiological evaluations, including wide-scale ABR assessment, to see whether there is a synchronization problem in the afferent auditory system in subjects with pSS. Consequently, medical experts should refer the subjects with pSS to extensive hearing assessments periodically for detect possible audiological damage. Further studies should comprehensively investigate the auditory neural pathways in not only pSS, but also in all the autoimmune diseases.
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SUMMARY
 The studies to date have often emphasized high frequency hearing loss in the autoimmune disease including pSS, but the hearing loss of the pSS subjects can be observed in all the frequencies.
 The hearing thresholds were in accordance with speech audiometry scores and acoustic reflex thresholds can be suffered from hearing loss.
 Also there is little research which investigates tympanogram values extensively, although all of the subjects had Type A curve in current study, the static compliances in pSSG were lower than those of the controls.
 Finally, in view of the main aim of this study, DPOAEs and suppression levels were researched differently from the literature and there is no statistically significant difference between the groups, so it demonstrates us that medial olivocochlear efferent system and outer hair cell functions cannot be suffered from pSS. 13 .5 (1.0-65.0) CRP, mg/L ¶ 4.0 (1.0-23.0) § data presented as mean ± SD; ¶ data presented as median (minmax); ANA, anti-nuclear antibody; RF, rheumatoid factor; ESR, erythrocyte sedimentation rate; CRP, c-reactive protein. 
